The diabetes testing product maker’s $86.8m Arkray 4U unit will seek out strategic entrepreneurs for its parent in areas such as digital medical equipment and functional food.
Japan-headquartered healthcare device producer Arkray has announced a ¥10bn ($86.8m) Singapore-based corporate venture capital initiative launched in a bid to back early-stage medical technology developers.
Formed in November 2021, Arkray 4U will invest directly from its parent firm’s balance sheet as opposed to a dedicated fund, Arkray 4U senior investment associate Wei Cong Seah told DealStreetAsia. It expects to provide up to $2.6m per deal.
Seah said the team is involved in the due diligence process for multiple startups but…
